首页> 外国专利> Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and prostate cancer risk

Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and prostate cancer risk

机译:循环胰岛素样生长因子-I,胰岛素样生长因子结合蛋白-3和前列腺癌的风险

摘要

Methods of predicting a propensity to developing prostate cancer are presented. The method consists of measuring the IGF status of individual. Individuals with high IGF status, as compared with normal reference range values, are at increased risk for developing prostate cancer. More particularly, the IGF status may be determined by measuring IGF-I levels and/or IGFBP-3 levels. High IGF and low IGFBP levels are indicative of a high IGF status. A method of determining the prognosis of existing prostate cancers or of monitoring disease progression involves determining the IGF/PSA status of an individual. Individuals with a high IGF/PSA status (both high IGF status and high PSA levels) tend to develop severe prostate cancer and have a poorer overall prognosis.
机译:提出了预测发展为前列腺癌的倾向的方法。该方法包括测量个人的IGF状态。与正常参考范围值相比,具有高IGF状态的个体患前列腺癌的风险增加。更具体地,可以通过测量IGF-1水平和/或IGFBP-3水平来确定IGF状态。高IGF和低IGFBP水平表示高IGF状态。确定现有前列腺癌的预后或监测疾病进展的方法涉及确定个体的IGF / PSA状态。具有高IGF / PSA状态(高IGF状态和高PSA水平)的个体倾向于发展为严重的前列腺癌,并且总体预后较差。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号